Cazenove Capital Management’s AbbVie ABBV Stock Holding History

Cazenove Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$244K	Buy	+5,899	New	+$258K	0.19%	66

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cazenove Capital Management's ABBV Position: Q2 2013 in Review

Cazenove Capital Management opened a new position in AbbVie (ABBV) in Q2 2013: 5,899 shares worth $244K. The stake represents 0.19% of the portfolio and ranks #66 among its holdings.

1,287 funds tracked by Wall St. Rank hold ABBV as of Q2 2013.

Cazenove Capital Management held 5,899 shares of AbbVie worth $244K as of Q2 2013.
AbbVie was a new Cazenove Capital Management position in Q2 2013.
AbbVie made up 0.19% of Cazenove Capital Management's portfolio in Q2 2013, its #66 holding.
1,287 funds tracked by Wall St. Rank held AbbVie as of Q2 2013.

Based on Cazenove Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.